OIE RL for «Surra » – «Philippe Büscher » – «Belgium»
OIE Reference Laboratory Reports
Activities in 2012
Address of laboratory / Institute of Tropical Medicine, Department of Biomedical Sciences, Unit of Parasite Diagnostics, Nationalestraat 155, B-2000 Antwerp, Belgium
Tel.: / +32 3 247 63 71
Fax: / +32 3 247 63 73
e-mail address: /
website: /
Name (including Title) of Head of Laboratory (Responsible Official): / Prof. Dr. Philippe Büscher
Name(including Title and Position) of OIE Reference Expert: / Dr. Ir. FilipClaes (till September 2012)
Prof. Dr. Philippe Büscher (from September 2012)
Date of submission to the OIE / January 2013
Instructions
This form should be used by an OIE Reference Laboratory to report activities that took place from January through December of the past year (2012), unless otherwise stated, and must be submitted by the end of January every year.
Only those activities that concern the disease (or topic) for which the laboratory is recognised by the OIE should be mentioned. The questionnaire structure follows the Terms of Reference (ToRs) for OIE Reference Laboratories, available at:
EachToR(blueitalicised text)has been placed as a heading covering the group of questions related to it.
Please note the reditalicisedtext is given as guidance and should be deleted from your report and substitute with your data. Examples are based onpast Annual Reports or have been invented.
The questionnaire represents a means of gathering information on activities carried out by OIE Reference Laboratories and making it available to OIE Member Countries and to the OIE Reference Laboratory network.
This annual report will remain available for consultation on the OIE web site:
(
ToR:To use, promote and disseminate diagnostic methods validated according to OIE Standards
Test recommended by the OIE / Total number of test performed last yearIndirect diagnostic tests / Nationally / Internationally
CATT / 12 / 724
ELISA / 2
Immune Trypanolysis / 501 / 4
Direct diagnostic tests / Nationally / Internationally
Blood smear
/ 5 / 309PCR M18S Trypanozoon
/ 1 / 2PCR 18S Trypanosomatidae
/ 1 / 2PCR RoTat 1.2 T. evansi
/ 1 / 2ToR:To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards.
Tostore and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease.
2.Did your laboratory produce or store imported standard reference reagentsofficially recognised by the OIE or other international bodies?
Yes No
3.Did your laboratory supply standard reference reagentsto OIE Member Countries?
Yes No
Type of reagent available / Related diagnostic test / Produced/stored / Amount supplied nationally (ml, mg) / Amount supplied internationally(ml, mg) / Name of recipient OIE Member Countries and of institutionsDNA from T. evansiAnTat 3.3 reference strain / PCR / produced / 0 / 2 µg / Lahore, Pakistan.
DNA from 1 T. evansi and 4 T. equiperdum strains / whole genome sequencing / produced / 30 µg each / Glasgow University, UK
Cryostabilates of T. theileri and T. evansi / in vivo culture and gene sequencing / produced / 2 vials of each strain / Friedrich Löffler Institute, Jena, Germany
rLATEX / antibody detection / produced / 5000 tests / Central Veterinary Research Laboratory, Dubai, UAE
25 positive and 25 negative control camel sera / antibody detection / stored / 50 x 0.3 ml / Central Veterinary Research Laboratory, Dubai, UAE
CATT/T.evansi / antibodydetection / produced / 2000 / ITM, Belgium
CATT/T.evansi / antibodydetection / produced / 250 / Xceltis, Germany
CATT/T.evansi / antibodydetection / produced / 0 / UNIGI, Germany
CATT/T.evansi / antibodydetection / produced / 2000 / CNRS, France
CATT/T.evansi / antibodydetection / produced / 2500 / US Army, USA
CATT/T.evansi / antibodydetection / produced / 500 / CMU, the Philippines
CATT/T.evansi / antibodydetection / produced / 1250 / SHEZHU, China
CATT/T.evansi / antibodydetection / produced / 250 / LMU, Germany
CATT/T.evansi / antibodydetection / produced / 250 / MAPA, Spain
CATT/T.evansi / antibodydetection / produced / 250 / LABKL, Germany
CATT/T.evansi / antibodydetection / produced / 750 / BASC, South Korea
CATT/T.evansi / antibodydetection / produced / 2500 / Lillidale, UK
CATT/T.evansi / antibodydetection / produced / 250 / SAG, Chile
CATT/T.evansi / antibodydetection / produced / 250 / LMU, Germany
CATT/T.evansi / antibodydetection / produced / 3750 / SHEZHU, China
CATT/T.evansi / antibodydetection / produced / 500 / RHS, Pakistan
CATT/T.evansi / antibodydetection / produced / 500 / RHS, Pakistan
CATT/T.evansi / antibodydetection / produced / 250 / Infallibles, Pakistan
CATT/T.evansi / antibodydetection / produced / 2500 / ARC, South Africa
CATT/T.evansi / antibodydetection / produced / 250 / LABKL, Germany
CATT/T.evansi / antibodydetection / produced / 1000 / Bio-Life, Tunesia
CATT/T.evansi / antibodydetection / produced / 3000 / STVS, Kenya
CATT/T.evansi / antibodydetection / produced / 250 / MAPA, Spain
CATT/T.evansi / antibodydetection / produced / 250 / IRD, France
CATT/T.evansi / antibodydetection / produced / 250 / CSIROS, Australia
CATT/T.evansi / antibodydetection / produced / 1250 / SHEZHU, China
CATT/T.evansi / antibodydetection / produced / 1250 / US Army, USA
CATT/T.evansi / antibodydetection / produced / 1000 / SCVL, Mongolia
CATT/T.evansi / antibodydetection / produced / 2500 / UNIGI, Germany
CATT/T.evansi / antibodydetection / produced / 1250 / Lillidale, UK
CATT/T.evansi / antibodydetection / produced / 500 / APHC, Singapore
CATT/T.evansi / antibodydetection / produced / 500 / IZS, Italy
CATT/T.evansi / antibodydetection / produced / 250 / BASC, South Korea
CATT/T.evansi / antibodydetection / produced / 3000 / GURAN, India
CATT/T.evansi / antibodydetection / produced / 250 / LMU, Germany
CATT/T.evansi / antibodydetection / produced / 1000 / NRC, Japan
CATT/T.evansi / antibodydetection / produced / 5000 / CVRL, United ArabEmirates
4.Did your laboratory produce diagnostic reagents other than the OIE-approved standard reference reagents?
Yes No
5.Did your laboratory produce vaccines?
Yes No
6.Did your laboratory supply vaccines to OIE Member Countries?
Yes No
ToR:To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases
7.Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease?
Yes No
8.Didyour laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease?
Yes No
ToR:To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries
9.Did your laboratory carry out diagnostic testing for other OIE Member Countries?
Yes No
Name of OIE Member Country seeking assistance / Date (dd/mm) / No. samples received for provision of diagnostic support (i.e. from surveillance campaign) / No. samples received for provision of confirmatory diagnosesNetherlands / 1-01-12 / 1
Germany / 1-01-12 / 1
Sweden / 2-01-12 / 2
Sweden / 3-01-12 / 3
UK / 4-01-12 / 5
Netherlands / 5-01-12 / 3
Portugal / 5-01-12 / 1
UK / 6-01-12 / 1
Germany / 6-01-12 / 1
France / 6-01-12 / 2
UK / 9-01-12 / 1
Germany / 10-01-12 / 7
Netherlands / 11-01-12 / 1
Germany / 11-01-12 / 1
Sweden / 11-01-12 / 1
Germany / 12-01-12 / 3
UK / 13-01-12 / 1
Austria / 13-01-12 / 1
Germany / 16-01-12 / 1
UK / 16-01-12 / 13
Germany / 17-01-12 / 1
UK / 17-01-12 / 1
Netherlands / 18-01-12 / 1
Germany / 23-01-12 / 1
Austria / 23-01-12 / 1
Austria / 24-01-12 / 1
Germany / 24-01-12 / 1
Portugal / 25-01-12 / 1
Netherlands / 25-01-12 / 2
UK / 26-01-12 / 2
Germany / 26-01-12 / 1
UK / 31-01-12 / 1
Germany / 1-02-12 / 1
Netherlands / 3-02-12 / 1
Germany / 3-02-12 / 2
Germany / 6-02-12 / 1
UK / 6-02-12 / 14
Netherlands / 7-02-12 / 1
UK / 8-02-12 / 1
Germany / 8-02-12 / 4
Germany / 8-02-12 / 1
Sweden / 10-02-12 / 1
United ArabEmirates / 14-02-12 / 2
Netherlands / 15-02-12 / 2
UK / 16-02-12 / 14
UK / 16-02-12 / 3
Germany / 17-02-12 / 3
Germany / 21-02-12 / 3
Netherlands / 22-02-12 / 1
CzechRepublic / 23-02-12 / 1
Germany / 24-02-12 / 1
Germany / 28-02-12 / 1
Belgium / 28-02-12 / 1
Netherlands / 29-02-12 / 1
UK / 29-02-12 / 2
France / 5-03-12 / 1
Austria / 5-03-12 / 1
UK / 6-03-12 / 1
Germany / 7-03-12 / 1
UK / 9-03-12 / 5
Germany / 9-03-12 / 2
Netherlands / 9-03-12 / 1
Finland / 9-03-12 / 2
UK / 13-03-12 / 2
Netherlands / 13-03-12 / 8
Germany / 13-03-12 / 1
UK / 14-03-12 / 2
Sweden / 15-03-12 / 1
Germany / 15-03-12 / 3
Netherlands / 15-03-12 / 1
UK / 15-03-12 / 1
Germany / 16-03-12 / 1
Germany / 19-03-12 / 1
UK / 20-03-12 / 3
Germany / 21-03-12 / 1
Netherlands / 27-03-12 / 1
Germany / 26-03-12 / 1
Germany / 27-03-12 / 2
UK / 28-03-12 / 1
Netherlands / 28-03-12 / 1
UK / 30-03-12 / 7
Germany / 3-04-12 / 2
Germany / 4-04-12 / 2
UK / 6-04-12 / 8
Netherlands / 6-04-12 / 1
UK / 11-04-12 / 1
UK / 16-04-12 / 2
Netherlands / 18-04-12 / 1
Netherlands / 20-04-12 / 1
UK / 23-04-12 / 2
Germany / 24-04-12 / 1
UK / 24-04-12 / 1
Germany / 24-04-12 / 1
UK / 26-04-12 / 1
Germany / 27-04-12 / 1
Netherlands / 27-04-12 / 1
UK / 27-04-12 / 1
UK / 30-04-12 / 12
UK / 2-05-12 / 1
Portugal / 2-05-12 / 1
Germany / 4-05-10 / 3
Germany / 4-05-12 / 1
UK / 8-05-12 / 2
Germany / 8-05-12 / 1
Finland / 9-05-12 / 1
UK / 9-05-12 / 1
Netherlands / 9-05-12 / 1
Netherlands / 11-05-12 / 1
UK / 11-05-12 / 1
UK / 14-05-12 / 1
UK / 14-05-12 / 2
UK / 15-05-12 / 1
Germany / 15-05-12 / 3
Netherlands / 16-05-12 / 1
UK / 18-05-12 / 1
CzechRepublic / 21-05-12 / 2
Germany / 22-05-12 / 1
Netherlands / 23-05-12 / 1
CzechRepublic / 23-05-12 / 1
Netherlands / 24-05-12 / 1
UK / 25-05-12 / 1
Germany / 29-05-12 / 1
Sweden / 29-05-12 / 1
Germany / 29-05-12 / 1
UK / 30-05-12 / 1
UK / 31-05-12 / 1
Germany / 1-06-12 / 1
Spain / 4-06-12 / 1
Netherlands / 5-06-12 / 1
Finland / 5-06-12 / 2
UK / 7-06-12 / 1
Netherlands / 7-06-12 / 1
Belgium / 7-06-12 / 1
Netherlands / 8-06-12 / 2
UK / 8-06-12 / 1
Germany / 11-06-12 / 1
Germany / 11-06-12 / 3
Germany / 12-06-12 / 2
Netherlands / 12-06-12 / 1
Netherlands / 15-06-12 / 2
Germany / 18-06-12 / 1
Finland / 18-06-12 / 2
Germany / 19-06-12 / 4
UK / 20-06-12 / 1
Netherlands / 20-06-12 / 1
Netherlands / 22-06-12 / 2
UK / 22-06-12 / 1
Belgium / 22-06-12 / 2
Germany / 25-06-12 / 1
UK / 25-06-12 / 1
Germany / 26-06-12 / 2
UK / 26-06-12 / 2
Germany / 28-06-12 / 1
UK / 28-06-12 / 1
Netherlands / 29-06-12 / 2
Germany / 29-06-12 / 1
Germany / 2-07-12 / 1
UK / 3-07-12 / 1
Germany / 3-07-12 / 4
Germany / 4-07-12 / 2
Netherlands / 4-07-12 / 1
Finland / 4-07-12 / 2
UK / 5-07-12 / 3
Netherlands / 5-07-12 / 2
Netherlands / 5-07-12 / 2
Germany / 5-07-12 / 2
Belgium / 6-07-12 / 3
UK / 6-07-12 / 1
UK / 9-07-12 / 3
Germany / 9-07-12 / 3
Finland / 10-07-12 / 2
Germany / 10-07-12 / 4
Germany / 12-07-12 / 4
UK / 12-07-12 / 13
UK / 13-07-12 / 1
Germany / 17-07-12 / 2
UK / 17-07-12 / 2
UK / 19-07-12 / 1
Sweden / 19-07-12 / 1
Germany / 20-07-12 / 4
Germany / 23-07-12 / 1
Netherlands / 25-07-12 / 1
Germany / 26-07-12 / 1
Netherlands / 27-07-12 / 2
Germany / 27-07-12 / 1
Germany / 30-07-12 / 5
UK / 30-07-12 / 2
Germany / 1-08-12 / 1
CzechRepublic / 6-08-12 / 2
CzechRepublic / 6-08-12 / 2
Germany / 7-08-12 / 1
UK / 7-08-12 / 2
Belgium / 8-08-12 / 2
Germany / 9-08-12 / 2
UK / 9-08-12 / 2
UK / 10-08-12 / 2
Germany / 10-08-12 / 1
UK / 14-08-12 / 3
CzechRepublic / 16-08-12 / 1
UK / 16-08-12 / 2
Netherlands / 16-08-12 / 1
UK / 17-08-12 / 1
Netherlands / 17-08-12 / 2
Germany / 20-08-12 / 2
UK / 20-08-12 / 1
UK / 22-08-12 / 2
Netherlands / 22-08-12 / 44
CzechRepublic / 23-08-12 / 2
Germany / 24-08-12 / 1
Netherlands / 29-08-12 / 1
UK / 29-08-12 / 1
UK / 31-08-12 / 1
CzechRepublic / 31-08-12 / 2
Germany / 3-09-12 / 1
UK / 3-09-12 / 2
Germany / 4-09-12 / 1
Sweden / 5-09-12 / 1
Netherlands / 5-09-12 / 4
Netherlands / 7-09-12 / 3
Sweden / 10-09-12 / 1
Germany / 11-09-12 / 5
Germany / 11-09-12 / 1
UK / 12-09-12 / 1
Germany / 13-09-12 / 5
Germany / 14-09-12 / 1
Netherlands / 14-09-12 / 2
UK / 18-09-12 / 1
Germany / 18-09-12 / 1
Germany / 18-09-12 / 5
France / 19-09-12 / 1
CzechRepublic / 19-09-12 / 1
Germany / 20-09-12 / 1
Netherlands / 21-09-12 / 1
Germany / 24-09-12 / 1
Belgium / 25-09-12 / 1
Germany / 25-09-12 / 1
Netherlands / 25-09-12 / 2
UK / 26-09-12 / 2
Germany / 27-09-12 / 1
UK / 28/912 / 2
Netherlands / 28/912 / 1
Germany / 28-09-12 / 1
UK / 1-10-12 / 2
Germany / 1-10-12 / 3
Germany / 2-10-12 / 2
UK / 2-10-12 / 1
Netherlands / 2-10-12 / 1
Germany / 3-10-12 / 1
UK / 3-10-12 / 2
UK / 5-10-12 / 14
Germany / 5-10-12 / 2
Germany / 8-10-12 / 1
UK / 9-10-12 / 1
Netherlands / 9-10-12 / 1
Germany / 9-10-12 / 6
UK / 9-10-12 / 1
Germany / 10-10-12 / 1
Netherlands / 10-10-12 / 1
Germany / 11-10-12 / 1
UK / 11-10-12 / 1
Netherlands / 12-10-12 / 1
UK / 15-10-12 / 1
Germany / 15-10-12 / 1
Germany / 15-10-12 / 2
Germany / 16-10-12 / 1
Netherlands / 17-10-12 / 19
Netherlands / 18-10-12 / 1
UK / 18-10-12 / 2
CzechRepublic / 19-10-12 / 2
Germany / 19-10-12 / 1
UK / 19-10-12 / 1
CzechRepublic / 19-10-12 / 1
UK / 22-10-12
Netherlands / 22-10-12 / 1
UK / 23-10-12 / 2
Germany / 23-10-12 / 1
Belgium / 24-10-12 / 1
Sweden / 24-10-12 / 1
Netherlands / 24-10-12 / 4
UK / 25-10-12 / 1
Germany / 25-10-12 / 2
Germany / 26-10-12 / 1
Italy / 26-10-12 / 1
UK / 29-10-12 / 1
Germany / 29-10-12 / 1
Germany / 30-10-12 / 1
Finland / 20-10-12 / 2
Netherlands / 31-10-12
CzechRepublic / 31-10-12 / 1
UK / 2-11-12 / 2
Germany / 2-11-12 / 2
UK / 5-11-12 / 3
Germany / 6-11-12 / 2
Germany / 7-11-12 / 2
Sweden / 8-11-12 / 1
CzechRepublic / 8-11-12 / 1
Germany / 8-11-12 / 1
UK / 9-11-12 / 4
Portugal / 9-11-12 / 1
Germany / 9-11-12 / 2
Germany / 12-11-12 / 1
UK / 13-11-12 / 2
Germany / 13-11-12 / 1
Netherlands / 13-11-12 / 3
Germany / 14-11-12 / 2
UK / 15-11-12 / 1
Netherlands / 15-11-12 / 1
UK / 16-11-12 / 1
Netherlands / 16-11-12 / 2
Germany / 16-11-12 / 2
Germany / 20-11-12 / 2
UK / 21-11-12 / 1
CzechRepublic / 22-11-12 / 1
Portugal / 21-11-12 / 1
CzechRepublic / 21-11-12 / 2
Germany / 22-11-12 / 1
Germany / 23-11-12 / 1
UK / 23-11-12 / 3
Netherlands / 23-11-12 / 23
CzechRepublic / 26-11-12 / 3
UK / 27-11-12 / 1
UK / 27-11-12 / 1
UK / 27-11-12 / 1
UK / 30-11-12 / 2
Germany / 27-11-12 / 1
Netherlands / 28-11-12 / 1
UK / 28-11-12 / 3
CzechRepublic / 29-11-12 / 4
Germany / 29-11-12 / 2
Netherlands / 30-11-12 / 1
UK / 4-12-12 / 1
Netherlands / 4-12-12 / 1
UK / 5-12-12 / 2
Germany / 5-12-12 / 2
Netherlands / 7-12-12 / 1
UK / 7-12-12 / 1
Germany / 7-12-12 / 2
Netherlands / 11-12-12 / 6
Belgium / 11-12-12 / 1
Germany / 12-12-12 / 1
Germany / 13-12-12 / 3
UK / 14-12-12 / 2
Germany / 14-12-12 / 2
Germany / 17-12-12 / 2
UK / 17-12-12 / 1
Germany / 18-12-12 / 2
Sweden / 18-12-12 / 1
Sweden / 19-12-12 / 1
UK / 19-12-12 / 1
Germany / 20-12-12 / 1
UK / 21-12-12 / 2
Germany / 21-12-12 / 1
UK / 24-12-12 / 1
Germany / 24-12-12 / 1
10.Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country?
Yes No
Name of the OIE Member Country receiving a technical consultancy / Purpose / How the advice was providedUS Army, USA / Advice on the implementation of diagnostic tests for surra in camels in Northern Africa / Remote assistance
Friedrich LöfflerInstitut, Jena, Germany / Advice about in vitro culture of African trypanosomes / remote assistance
ToR:To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations
11.Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own?
Yes No
Title of the study / Duration / Purpose of the study / Partners (Institutions) / OIE Member Countries involved other than your countryWhole genome sequencing of T. equiperdum and T. evansi / 3 years / Identifying species specific sequences with differential diagnostic potential / Katholieke Univeristeit Leuven
Glasgow University
ANSES, Dozulé
University Simon Bolivar / UK
France
Venezuela
Recombinant Antigen Test for Trypanosomiasis / 2 years / Development of rapid diagnostic tests for surra based on recombinant antigens / CorisBioConcept, Gembloux
Central Veteriniary Research Laboratory, Dubai / United Arab Emirates
ToR:To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases
12.Didyour Laboratory collect epizootiologicaldata relevant to international disease control?
Yes No
13.Didyour laboratory disseminate epizootiologicaldata that had been processed and analysed?
Yes No
14.What method of dissemination of information is most often used by your laboratory?
(Indicate in the appropriate box the number by category)
a)Articles published in peer-reviewed journals:...... 2
b)International conferences:...... 7
c)National conferences:...... 0
d)Other (IAEA consultant meeting)...... 1
ToR: To provide scientific and technical training for personnel from OIE Member Countries
To recommend the prescribed and alternative tests or vaccines as OIE Standards
15.Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries?
Yes No
If the answer is yes, please provide the total number of trained persons for each of the following categories:
a)Technical visits:...... 1
b)Seminars:......
c)Hands-on training courses:......
d)Internships (>1 month):......
Type of technical training provided (a, b,c or d) / Country of origin of the expert(s) provided with training / No. participants from the corresponding countryaIsolation of trypanosomes from infected rat blood by means of anion exchange chromatography / France / 1
ToR:To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned
16.Does your laboratory have a Quality Management System certified according to an International Standard?
Yes No
Quality management system adoptedISO 17025
17.Is your laboratory accredited by an international accreditation body?
Yes No
18.Does your laboratory maintain a “biorisk management system” for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2012, Chapter 1.1.3 orManual of Diagnostic Tests for Aquatic Animals 2012, Chapter 1.1.1)
Yes No
ToR:To organise and participate in scientific meetings on behalf of the OIE
19.Did your laboratory organise scientific meetings on behalf of the OIE?
Yes No
20.Did your laboratory participate in scientific meetings on behalf of the OIE?
Yes No
ToR:To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results
21.Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease?
Yes No
22.Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests?
Yes No
23.Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest?
Yes No
Title of the project or contact / Scope / Name(s) of relevant OIE Reference LaboratoriesEPIZONE / Develop a full genome sequence approach within OIE RLs / OIE RL for FMD, Russia and OIE RL for FMD, UK
ToR:To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results.
24.Did your laboratory organiseor participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease?
Yes No
Purpose for inter-laboratory test comparisons[1] / No. participating laboratories / Participating OIE Member CountriesTo evaluate a new rapid diagnostic test for surra (rLATEX/T.evansi) / 2 / Belgium, United Arab Emirates
ToR:To place expert consultants at the disposal of the OIE
25.Did your laboratory place expert consultants at the disposal of the OIE?
Yes No
Kind of consultancy / Location / Subject (facultative )Provision of comments on OIE Terrestrial Manual / Belgium / Revision of OIE Terrestrial Manual chapter 2.1.17 Trypanosomaevansi infection (surra)
Provision of comments on OIE Terrestrial Manual / Belgium / Revision of OIE Terrestrial Manual chapter 2.5.3. Dourine
______
Annual reports of OIE Reference Laboratories, 20121
[1]See Interlaboratory test comparisons in: Laboratory Proficiency Testing at:
see point 1.3